An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.

Seventy-nine patients with probable Alzheimer's disease were enrolled into a double-blind, placebo-controlled cross-over study to assess the therapeutic effect and safety of THA (tetrahydroaminoacridine; tacrine) without concomitant lecithin administration. Forty-one patients completed the tria...

Full description

Bibliographic Details
Main Authors:	Wilcock, G, Surmon, D, Scott, M, Boyle, M, Mulligan, K, Neubauer, K, O'Neill, D, Royston, V
Format:	Journal article
Language:	English
Published:	1993

Similar Items

Cholinergic side-effects of tetrahydroaminoacridine.
by: Wilcock, G, et al.
Published: (1988)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1990)

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
by: Wilcock, G
Published: (1994)

Dementia and driving.
by: O'Neill, D, et al.
Published: (1992)

How a foreigner invented "Buddendom" in Burmese - from tha-tha-na to bok-da' ba-tha
by: Houtman, G
Published: (1990)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1993)

Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.
by: Rupniak, N, et al.
Published: (1990)

Longitudinal diagnosis of memory disorders.
by: O'Neill, D, et al.
Published: (1992)

Al-Tha'ir al-Ahmar /
by: 297059 Ali Ahmad Bakthir
Published: (1953)

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
by: Wilcock, G, et al.
Published: (2008)

Can blood concentrations of tacrine hydrochloride (THA) predict the risk of adverse effects?
by: Ford, J, et al.
Published: (1993)

Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study.
by: Forsyth, DR, et al.
Published: (1989)

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
by: Pirttilä, T, et al.
Published: (2004)

Variability in scoring the Hachinski Ischaemic Score.
by: O'Neill, D, et al.
Published: (1995)

DIFFERENTIAL DRIVING SKILLS IN DEMENTIA
by: Oneill, D, et al.
Published: (1991)

DVT prophylaxis after THA: more hype than help.
by: Murray, D
Published: (2000)

DVT prophylaxis after THA: More hype than help
by: Murray, D
Published: (2000)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (vol 321, pg 1445, 2000)
by: Wilcock, G
Published: (2001)

Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type
by: Wilcock, G, et al.
Published: (1997)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
by: Wilcock, G, et al.
Published: (2000)

Tha factors in influencing knowledge entrepreneurship in Malaysia manufacturing companies.
by: Jusoh, Rosnani, et al.
Published: (2010)

Towards gaining tha competitive edge : lecture of the year 2001
Published: (2001)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9) (1445-1449))
by: Wilcock, G
Published: (2001)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9)(1445-1449))
by: Wilcock, G
Published: (2001)

β-Cyclodextrin/lecithin: preparation and characterization
by: Eng, Hui Peng, et al.
Published: (2017)

Volumetric Studies Of Lecithin-Water Dispersions
by: Yeap, Pei Koon
Published: (2007)

Efficacy and safety of tarenflurbil, a selective a beta 42-lowering agent, in Alzheimer's disease (AD): A phase 2 trial of up to 24 months of treatment
by: Black, S, et al.
Published: (2008)

Moringa oleifera as a potential source of lecithin
by: Leong, Siew Yin
Published: (2012)

Effects of lecithin as emulsifier on the performance of turkey poults
by: Halim, Siti Nurzihanum
Published: (2015)

Light scattering studies on lecithin micellar solution
by: Chamberlin, Richard Addison
Published: (2005)

Efficacy and safety of tarenflurbil (flurizan), a selective Abeta42-lowering agent, in Alzheimer's disease (AD): A phase 2 trial of up to 24 months of treatment
by: Wilcock, G, et al.
Published: (2007)

Determinants of entrepreneurial intention :: Tha Case of PT Telkom Indonesia Corporate Office
by: , PURBA, Chandra GT, et al.
Published: (2004)

Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase.
by: Koo, D, et al.
Published: (2001)

The increasing burden of Alzheimer disease.
by: Sadik, K, et al.
Published: (2003)

Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies
by: Wilcock, G, et al.
Published: (2002)

Tacrine for senile dementia of Alzheimer's or Lewy body type.
by: Wilcock, G, et al.
Published: (1994)

Neurotrophins in Alzheimer's disease
by: Wilcock, G
Published: (2002)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
by: Schneider, L, et al.
Published: (2011)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
by: Schneider, L, et al.
Published: (2011)